Anti-Coagulants Physical Process of Clotting

Slides:



Advertisements
Similar presentations
Haemostasis Prof. K. Sivapalan.
Advertisements

PLATELETS (PLT) Thrombocytes. PLATELETS (PLT) Thrombocytes.
Hemostasis: Dr.Faten Hemostasis: Hemo/Stasis Hemo=BleedigStasis=Stop.
HEMOSTASIS (STEPS OF)‏
Cardiovascular System: Blood
Coagulation Just the basics.... Three steps Vasoconstriction Platelet plug formation Fibrin clot formation.
HEMOSTASIS. Due to damaged blood vessels Events that stop bleeding.
Vascular Pharmacology
Blood coagulation involves a biological amplification system in which relatively few initiation substances sequentially activate by proteolysis a cascade.
Drmsaiem FIBRINOLSIS SYSTEM DR MOHAMMED SAIEMALDAHR Faculty of Applied Medical Sciences Medical Technology Dep.
Principles of anticoagulant tratment
Antithrombin III Independent Anticoagulants Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
ENZYME CASCADES: BLOOD CLOTTING
Hemostasis and Blood Coagulation
Dubravka Šipuš, 2nd year 2013/2014 Mentor: A. Žmegač Horvat.
Section 10: Nutrients and their functions Vitamin K and blood clot formation 01/27/06.
Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
Thrombin and Blood Clotting Thrombin is the final enzyme in the coagulation cascade (Figure 1) at sites of vascular injury and serves as the link between.
Hemostasis Constriction of vessel Aggregation of platelets
Coagulation Mechanisms
Clot Formation Review with Animations
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
Blood Clotting Pathway. Prothrombin Thrombin Vitamin K Adds γCOO- to glutamate of prothrombin Also VII IX X Coumadin Inhibits vit K action.
Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to to describe different classes of anti-platelet.
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
PHYSIOLOGIC CONTROL OF HEMOSTASIS MLAB Coagulation Keri Brophy-Martinez.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Principles of Pharmacology The Pathophysiologic Basis of Drug Therapy.
Coagulation and fibrinolysis
بسم الله الرحمن الرحيم.
Blood Clotting In the absence of blood vessel damage, platelets are repelled from each other and from the endothelium of blood vessels. When a blood vessel.
II. Antiplatelet Drugs.
Platelets (Thrombocytes)
Factors against intravascular clotting]
HAEMOSTASIS AND THROMBOSIS Regulation of coagulation
These factors prevent blood clotting - in normal state.
Activation of the Hemostatic System During Cardiopulmonary Bypass
Activation of the Hemostatic System During Cardiopulmonary Bypass
Anticoagulants in the Treatment of Venous Thromboembolism
ANTICOAGULANT.
What is haemostasis? Coagulation Fibrinolysis
Med Chem Tutoring for Anticoagulants, Antiplatelets, and Thrombolytics
Drugs Used in Coagulation Disorders
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
Cardiovascular System: Blood
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
Hemodynamic disorders (1 of 3)
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Anti-Coagulants Physical Process of Clotting
Implant of a Medical Device and the Wound Healing Process.
ANTICOAGULANT DRUGS Dr.V.V.Gouripur.
Platelets in Atherothrombosis
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
Figure 1 Mechanism of thrombus formation during ST-segment
George J. Despotis, MD, Michael S. Avidan, MD, Charles W. Hogue, MD 
Paul A. Gurbel, and Udaya S. Tantry JCHF 2014;2:1-14
Clinical Aspects of Biochemistry
Platelet receptors and their antagonists.
Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies  C.P.R. Walker, D. Royston 
Anti-Coagulants Physical Process of Clotting
Hemostasis and blood coagulation Dr.sahar j kadhum
Antiplatelet Drugs Dr. : Asmaa Fady MD., MSC, M.B, B.Ch
HEMOSTASIS (Stages of Blood Clotting)‏
A simplified representation of the coagulation cascade.
Section B: Science update
How I treat disseminated intravascular coagulation
Effects of vitamin K antagonists (VKA), such as warfarin, low-molecular-weight heparin (LMWH), and dabigatran, on the coagulation pathway. Effects of vitamin.
Presentation transcript:

Anti-Coagulants Physical Process of Clotting Chemical Process of Clotting Fibrin formation, extrinsic and intrinsic pathways Anti-coagulants Definition Heparin, Low molecular weight heparins, pentasaccharide Structure, properties, biochemical mechanism Coumarins and 1,3-indanediones 12/5/2018 MEDC 604 Anti-coagulants

A) Physical Process B) Chemical Process The Clotting Process A) Physical Process B) Chemical Process Wound antithrombins factor Xa thrombin prothrombin fibrinogen fibrin (monomers) (polymer) vitamin K-dependent g-carboxylation of Glu residues coumarins platelet activation release thrombin release of of ADP generation thromboxane A2 Further activation of platelets Platelet aggregation aspirin ADP receptor antagonists GP IIb-IIIa CLOT Taken from Desai UR (2004) Med. Res. Rev. 24, 151-181. 12/5/2018 MEDC 604 Anti-coagulants

Physical Process of Clotting 12/5/2018 MEDC 604 Anti-coagulants

Chemical Process of Clotting 12/5/2018 MEDC 604 Anti-coagulants

Heparin and Low molecular weight heparins Structure and sequence 12/5/2018 MEDC 604 Anti-coagulants

Pentasaccharide 12/5/2018 MEDC 604 Anti-coagulants

Biochemical Mechanism of Heparin Action AT + H AT:H AT-E + H E 12/5/2018 MEDC 604 Anti-coagulants

Direct Thrombin Inhibitors HIRUDIN – Isolated from leech, hirudino medicinalis. A polypeptide consisting of 65 amino acid residues that binds thrombin in the active site as well as another site called exosite I 12/5/2018 MEDC 604 Anti-coagulants

Coumarins and 1,3-indanediones 12/5/2018 MEDC 604 Anti-coagulants

Clinically useful coumarins and 1,3-indanediones 12/5/2018 MEDC 604 Anti-coagulants

Biochemical Mechanism of Action 12/5/2018 MEDC 604 Anti-coagulants